Michael Shum is the Director of the Business Improvement and Support Section within the Complementary and OTC Medicines Branch at the Therapeutic Goods Administration at the Australian Government Department of Health.
He is responsible for coordinating regulatory reforms and business improvements to the complementary medicine regulatory framework. In previous roles at the TGA Michael has worked in medical devices, prescription and OTC medicines regulatory reform and product evaluation.
Presentation Title: Update on reforms to the Australian regulatory framework covering complementary medicines
1:00-2:00pm, Friday 17 May 2019
The Complementary and OTC Medicines branch is continuing to implement reforms to the regulatory framework covering complementary medicines arising from the Review of Medicines and Medical Devices Regulation (MMDR). These reforms focus on the listed medicine framework but also covered registered complementary medicines. This presentation will describe the current status of the MMDR reforms as well as other relevant changes to the therapeutic goods legislation and how the changes may affect the traditional Chinese medicines industry.